Healthcare costs of invasive meningococcal disease: a nationwide population-based study using an innovative clustering method to identify sequelae.

ABSTRACT:

Background

Studies investigating the costs associated with invasive meningococcal disease (IMD) are scarce, primarily due to the disease rarity, its highly variable prognosis, and the potential for sequelae to develop long after the acute phase. We conducted a retrospective longitudinal cohort study to estimate the healthcare costs associated with IMD in France in the short (one month), medium (two years), and long (up to 12 years) term.

Methods

Using the National Health Data System (SNDS), we extracted data for all individuals hospitalised with a diagnosis of IMD (IMD+) between 1 January 2008 and 31 December 2018. Each IMD + individual was matched to up to four individuals without IMD. Among IMD + individuals discharged alive (exposed individuals), a K-modes clustering meth

SUBMITTER: Duval X 

PROVIDER: S-EPMC12604408 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature